Low Back Pain Evaluation and Treatment ApproachesThis session was recorded at the Pri-Med Southwest Annual Conference

Low back pain (LBP) is a leading cause of disability and a frequent concern in primary care. This session provides an in-depth, spine-focused perspective on evaluating and managing LBP. Participants will learn to differentiate between mechanical and non-mechanical causes, use diagnostic tools efficiently, and implement evidence-based treatment strategies. The session will also address when to refer patients for specialist evaluation and explore the latest advancements in both conservative and interventional care.

CME/CE Information

1.00 AMA PRA Category 1 Credits™ or 0.97 AANP

Release Date: 4/12/2025

Expiration Date: 5/25/2025

Topics

Faculty

Lorenzo Deveza, MD, PhD

Learning Objectives

Discuss the epidemiology and common etiologies of low back pain
Identify red flags that indicate the need for referral and/or imaging
Compare noninvasive and surgical treatment options, incorporating evidence-based guidelines
Evaluate the role of physical therapy and psychosocial factors in patient outcomes
Develop a structured approach to mapping treatment pathways based on clinical presentation and best practices

Faculty

Lorenzo Deveza, MD, PhD

Associate Professor, Orthopaedic Surgery, Baylor College of Medicine, Houston, Texas

Learn More

Disclosures

The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All have been mitigated by Pri-Med Institute:

Richard J. Hamill, MD (moderator and planner): Researcher for Pfizer and independent contractor for PPD, Inc.

All other individuals in control of content for this activity have disclosed no relevant financial relationships.

CME/CE Information

AMA PRA Category 1 Credits™

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners^® as an approved provider of nurse practitioner continuing education. Provider number: 040308.

Designation Statement

This activity is approved for 0.97 contact hour, which includes 0 hour of pharmacology.

Fine Print

Computer System Requirements

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Statement of Independence

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Disclosure Policies and Contacting Pri-Med Institute

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.